The largest database of trusted experimental protocols

Pgl4.18 luc2p neo

Manufactured by Promega
Sourced in United States

PGL4.18 [luc2P/Neo] is a reporter vector that contains the luc2P luciferase gene and a neomycin resistance gene for selection in mammalian cells. The luc2P luciferase gene is a codon-optimized version of the firefly luciferase gene, providing high levels of luminescent signal. The neomycin resistance gene allows for selection of stable cell lines expressing the reporter.

Automatically generated - may contain errors

3 protocols using pgl4.18 luc2p neo

1

IGFBP2 Promoter Luciferase Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
A 1.5 kb fragment of the proximal IGFBP2 promoter was amplified with the following primer set: IGFBP2-For: 5′-CAGGGTACCCTGTGCCCTTGCTAACCGCCCATTTC-3′, IG FBP2-Rev: 5′-CAGGCTAGCCGGGTCCTAAGGGCCGGCTTCTCC-3′ (restriction enzyme site KpnI and NheI were underlined). The DNA fragment was inserted into the luciferase reporter vector pGL4.18 [luc2P/Neo] (Promega Corporation, Madison, Wisconsin, United States) by KpnI and 3′ NheI (IGFBP2-pGL4.18). For luciferase reporter assay, 5 × 104 HEK293T cells were cultured in 12-well plates overnight. Next day, cells were transfected with 1 μg of with lentiviral empty vector or lenti-RUNX2 together with 20 ng of IGFBP2-pGL4.18 and Renilla luciferase pGL4.74 [hRluc/TK] plasmid (Promega, Madison, WI, United States) using PolyJetTM In Vitro DNA Transfection Reagent (SignaGen Laboratories, Rockville, MD, United States). At 48 h post transfection, luciferase activity in each well was measured by Dual-Luciferase® Reporter Assay System (Promega) and normalized to Renilla.
+ Open protocol
+ Expand
2

Plasmid Construction and Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasmid pGL4‐ARR2PB‐luc was constructed by cloning ARR2PB fragment into pGL4.18 [luc2P/Neo] (#E6731, Promega). Plasmid pCMV‐hAR (#89 078, Addgene) was a gift from Elizabeth Wilson. Plasmids hARF876L, hARF876L/T877A, hART877G, and hARW741C were constructed by site‐directed mutagenesis of pCMV‐hAR through overlap extension PCR.
PC3 cells were propagated in RPMI‐1640 (#MA0215, Meilunbio) supplemented with 10% fetal bovine serum (FBS, #F8318, Sigma‐Aldrich). NIH3T3 cells were cultured in DMEM (#MA0212, Meilunbio) with 10% FBS. All growth media were supplemented with 1% Penicillin–Streptomycin–Glutamine (#10 378 016, Gibco). Cell cultures were maintained in culture flasks in 5% CO2 atmosphere at 37 °C. To avoid the disturbance of relevant endogenous factors in FBS, FBS were stripped with dextran‐coated charcoal (DCC) to remove most of its hormone, growth factors, and cytokines. Phenol red‐free media along with 5% DCC‐stripped serum‐starvation (CSS) were used for treatment studies.
+ Open protocol
+ Expand
3

Transcriptional Regulation of TGFB1 Promoter

Check if the same lab product or an alternative is used in the 5 most similar protocols
The full length TGFB1 promoter regions, sequence 1 (0 to -500 bp region of TGFB1 promoter) and sequence 2 (-1500 to -2000 bp region of TGFB1 promoter) were cloned into the vector pGL4.18[luc2P/Neo] (Promega Corp., Fitchburg, WI, USA). An AP-1 reporter vector (pGMAP-1 Lu) with the AP-1 response element was purchased from Genomeditech, LTD (Shanghai, China). Cells were cotransfected with the indicated plasmids together with the reporter plasmid and the pGL4.74[hRluc/TK] vector using the liposome method. Cells were harvested 24 h later, and then firefly and Renilla luciferase activities were assayed with dual-luciferase assay system (Promega Corp., Fitchburg, WI, USA) according to the manufacturer's instructions. Firefly luciferase activity was normalized to Renilla luciferase activity. All experiments were, performed in triplicate, and the luminescence values for each group were statistically analysed.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!